Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Imbach

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
Pediatric Blood & Cancer|August 9, 2005
Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS)P Imbach, T Kühne, D Müller, et al.
Schweizerische Medizinische Wochenschrift|October 14, 1978
[Acute "high risk" and "low risk" juvenile lymphatic leukemia (proceedings)]P Imbach, W Berchtold, A Feldges, et al.
Acta Haematologica|January 1, 1986
Reactivity of monoclonal antibodies LAU-A1 and anti-Y 29/55 in T and B cell malignancies of children: correlation with immunological markers and clinical dataA Hirt, S Carrel, H K Forster, et al.
Schweizerische Medizinische Wochenschrift|July 24, 1982
[Chance of a second remission in acute juvenile lymphoblastic leukemia with favorable prognosis]A Feldges, P Imbach, A Lüthy, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1990
Immunomodulation by intravenous immunoglobulinP Imbach, S Barandun, H Cottier, et al.
Human Immunology|November 1, 1983
Evidence for HLA-linked susceptibility factors in childhood leukemiaV E Von Fliedner, H Merica, M Jeannet, et al.
Helvetica Paediatrica Acta|September 1, 1985
[Effect of two years of deferoxamine therapy on iron balance, ferritin, liver and heart in patients with thalassemia major]A Flückiger, P Imbach, E Pfenninger, et al.
Lancet (London, England)|February 18, 1984
Acute myelogenous leukaemia: maintenance chemotherapy after early consolidation treatment does not prolong survivalC Sauter, W Berchtold, M Fopp, et al.
Lancet (London, England)|September 10, 1994
Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpuraV Blanchette, P Imbach, M Andrew, et al.
Bioorganic & Medicinal Chemistry Letters|June 8, 2001
A new structural class of selective and non-covalent inhibitors of the chymotrypsin-like activity of the 20S proteasomeC García-Echeverría, P Imbach, D France, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Pediatric Blood & Cancer|August 9, 2005
Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS)P Imbach, T Kühne, D Müller, et al.
Schweizerische Medizinische Wochenschrift|October 14, 1978
[Acute "high risk" and "low risk" juvenile lymphatic leukemia (proceedings)]P Imbach, W Berchtold, A Feldges, et al.
Acta Haematologica|January 1, 1986
Reactivity of monoclonal antibodies LAU-A1 and anti-Y 29/55 in T and B cell malignancies of children: correlation with immunological markers and clinical dataA Hirt, S Carrel, H K Forster, et al.
Schweizerische Medizinische Wochenschrift|July 24, 1982
[Chance of a second remission in acute juvenile lymphoblastic leukemia with favorable prognosis]A Feldges, P Imbach, A Lüthy, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1990
Immunomodulation by intravenous immunoglobulinP Imbach, S Barandun, H Cottier, et al.
Human Immunology|November 1, 1983
Evidence for HLA-linked susceptibility factors in childhood leukemiaV E Von Fliedner, H Merica, M Jeannet, et al.
Helvetica Paediatrica Acta|September 1, 1985
[Effect of two years of deferoxamine therapy on iron balance, ferritin, liver and heart in patients with thalassemia major]A Flückiger, P Imbach, E Pfenninger, et al.
Lancet (London, England)|February 18, 1984
Acute myelogenous leukaemia: maintenance chemotherapy after early consolidation treatment does not prolong survivalC Sauter, W Berchtold, M Fopp, et al.
Lancet (London, England)|September 10, 1994
Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpuraV Blanchette, P Imbach, M Andrew, et al.
Bioorganic & Medicinal Chemistry Letters|June 8, 2001
A new structural class of selective and non-covalent inhibitors of the chymotrypsin-like activity of the 20S proteasomeC García-Echeverría, P Imbach, D France, et al.
Pageof 12